Clinical trial · Observational
Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute
Frequency of SARS COV-2 Infection Among Malignant Patients at South Egypt Cancer Institute
NCT05465759CI-TRIAL-00059754unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Assessment the frequency of SARS COV-2 infection among malignant patients at south Egypt Cancer institute
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| COVID-19 | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| disease | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- calculate the frequency of SARS-CoV-2 infection among patients with malignant data collection during the study period
- timeFrame
- 1 year
- description
- To calculate the rate of SARS-CoV-2 infection among patients with malignant data collection within covid-19 pandemic either retrospective or prospective. Data will include : patient demography such as Age,sex,smoking status,cancer type cancer treatment (patient on chemotherapy or radiotherapy if available), symptoms, signs and laboratory parameters of COVID -19. outcome including hospitalization or ICU admission and mortality rate will be recorded
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Malignant patients. * PCR positive for covid-19 Exclusion Criteria: * PCR negative for covid-19
References
Publications (0)
Data not yet available
No reference posted for this study.